Severe hepatopulmonary syndrome with hypoxemia refractory to liver transplant : recovery after 67 days of ECMO support
dc.contributor.author | Silva, Rodrigo Piltcher da | pt_BR |
dc.contributor.author | Chedid, Márcio Fernandes | pt_BR |
dc.contributor.author | Grezzana Filho, Tomáz de Jesus Maria | pt_BR |
dc.contributor.author | Leipnitz, Ian | pt_BR |
dc.contributor.author | Araujo, Alexandre de | pt_BR |
dc.contributor.author | Gazzana, Marcelo Basso | pt_BR |
dc.contributor.author | Saueressig, Mauricio Guidi | pt_BR |
dc.contributor.author | Lorenzi, William | pt_BR |
dc.contributor.author | Cardoni, Mario Gurvitez | pt_BR |
dc.contributor.author | Bellaver, Priscila | pt_BR |
dc.contributor.author | Álvares-da-Silva, Mário Reis | pt_BR |
dc.contributor.author | Feier, Flávia Heinz | pt_BR |
dc.contributor.author | Chedid, Aljamir Duarte | pt_BR |
dc.contributor.author | Kruel, Cleber Rosito Pinto | pt_BR |
dc.date.accessioned | 2023-11-17T03:24:49Z | pt_BR |
dc.date.issued | 2022 | pt_BR |
dc.identifier.issn | 0391-3988 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/267200 | pt_BR |
dc.description.abstract | Hepatopulmonary syndrome (HPS) is a complication of end stage liver disease (ESLD) and is manifested by severe hypoxemia, which usually responds to liver transplantation (LT). As compared to patients undergoing LT for other etiologies, patients with HPS present an increased risk of postoperative morbidity and mortality. There is no effective treatment for patients whose hypoxemia does not respond to LT. This subset of patients is at a highly increased risk of death. There are very few reports on the use of extracorporeal membrane oxygenation (ECMO) in this setting with rapid response. However, there is no prior report of ECMO utilization for longer than 4 weeks. We present the case of a 17 year-old male patient who underwent LT for ESLD secondary to chronic portal vein thrombosis and HPS. He received a liver from a deceased donor and presented with severe HPS after LT, requiring ECMO support for 67 days. The patient was discharged home and is breathing in ambient air. He is currently asymptomatic and has a normal liver function. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | The international journal of artificial organs. Thousand Oaks. Vol. 45, no. 1 (2022), p. 212-123. | pt_BR |
dc.rights | Open Access | en |
dc.subject | Artificial lung & respiratory support | en |
dc.subject | Doença hepática terminal | pt_BR |
dc.subject | Oxigenação por membrana extracorpórea | pt_BR |
dc.subject | Intravascular oxygenators | en |
dc.subject | ECMO | en |
dc.subject | Síndrome hepatopulmonar | pt_BR |
dc.subject | Hipóxia | pt_BR |
dc.subject | Liver transplantation | en |
dc.subject | Apheresis & detoxification techniques | en |
dc.subject | Transplante de fígado | pt_BR |
dc.subject | Artificial kidney | en |
dc.title | Severe hepatopulmonary syndrome with hypoxemia refractory to liver transplant : recovery after 67 days of ECMO support | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001185921 | pt_BR |
dc.type.origin | Estrangeiro | pt_BR |
Este item está licenciado na Creative Commons License
![](/themes/Mirage2Novo//images/lume/cc.png)
-
Artigos de Periódicos (39352)Ciências da Saúde (10588)